Controversial agrochemicals giant Syngenta has extensive academic, research and professional ties to the University of York, a Nouse investigation can reveal. Pesticides produced and exported by ...

Upon U.S. registration, isocycloseram, the AI found in Opello and Equento insecticides, will provide early-season insect ...

Syngenta, which has a major operational base in Greensboro, said Wednesday it has signed an agreement to acquire certain product rights from Novartis, along with the recent opening of its ...

The transaction includes the Novartis repository of natural compounds and genetic strains for agricultural use.

Syngenta has acquired Novartis’ natural products and genetic strains assets to enhance its biologicals research capabilities and support the agri ...

Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and ...

Syngenta, a world leader in developing the next generation of biologicals products for agricultural use, is significantly ...

"We're still very cautious," says Heinz Imhof, head of Novartis's agribusiness unit and chairman designate of the new combined company, to be called Syngenta AG. "Agricultural commodity prices haven't ...

Novartis has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, its chief executive ...

Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...

With its Q4 2024 financials on Friday, Novartis (NYSE:NVS) (OTCPK:NVSEF) indicated a delayed timeline for initial data from a Phase 3 trial for a cardiac therapy it co-develops with Ionis ...

Ionis (IONS) partner Novartis (NVS) shared in their year-end earnings report that Phase 3 pelacarsen data is now expected in the first half of 2026 with subsequent regulatory submissions in the ...